Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification

CompletedOBSERVATIONAL
Enrollment

1,050

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

November 19, 2021

Study Completion Date

October 1, 2022

Conditions
Preeclampsia and EclampsiaPreeclampsia SevereGestational HypertensionChronic Hypertension in Obstetric ContextSuperimposed Pre-EclampsiaPreeclampsia Mild
Trial Locations (18)

18102

Lehigh Valley Health Network, Allentown

21237

MedStar Health, Baltimore

21287

Johns Hopkins University Medical Center, Baltimore

33606

University of South Florida, Tampa

43210

Ohio State University Wexner Medical Center, Columbus

45409

Miami Valley Hospital, Dayton

60201

Northshore, Evanston

60637

University of Chicago Medical Center, Chicago

77030

Baylor College of Medicine, Houston

84132

University of Utah, Salt Lake City

90048

Cedars-Sinai Medical Center, Los Angeles

90505

Torrance Memorial Medical Center, Torrance

92123

Sharp Mary Birch Hospital for Women & Newborns, San Diego

94158

UC San Francisco Medical Center, San Francisco

02111

Tufts Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01605

University of Massachusetts Memorial Medical Center, Worcester

27599-7516

University of North Carolina Medical Center- Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

ThermoFisher Scientific Brahms Biomarkers France

INDUSTRY

lead

Cedars-Sinai Medical Center

OTHER

NCT03815110 - Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification | Biotech Hunter | Biotech Hunter